Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
Journal of Hepatology|September 21, 2020
Letter regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement"Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Hepatology International|June 23, 2011
The use of transient elastography in the management of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Hepatology International|November 21, 2019
Use of HBsAg quantification in the natural history and treatment of chronic hepatitis BLung-Yi Mak, Wai-Kay Seto, James Fung, et al.
Expert Opinion on Emerging Drugs|March 5, 2016
Emerging drugs for the treatment of hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Hepatology International|June 21, 2011
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfectionWai-Kay Seto, Man-Fung Yuen, James Fung, et al.
Journal of Clinical Gastroenterology|August 24, 2012
Future prevention and treatment of chronic hepatitis B infectionWai-Kay Seto, James Fung, Man-Fung Yuen, et al.
Gut and Liver|March 29, 2019
New Biomarkers of Chronic Hepatitis BLung-Yi Mak, Wai-Kay Seto, James Fung, et al.
Journal of Gastroenterology and Hepatology|April 2, 2019
Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: A population-based studyKa Shing Cheung, Lijia Chen, Wai Kay Seto, et al.
Clinical and Molecular Hepatology|November 21, 2024
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis BSaisai Zhang, Lung-Yi Mak, Man-Fung Yuen, et al.
Clinical and Molecular Hepatology|November 30, 2022
Screening strategy for non-alcoholic fatty liver diseaseSaisai Zhang, Lung-Yi Mak, Man-Fung Yuen, et al.
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
Journal of Hepatology|September 21, 2020
Letter regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement"Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Hepatology International|June 23, 2011
The use of transient elastography in the management of chronic hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Hepatology International|November 21, 2019
Use of HBsAg quantification in the natural history and treatment of chronic hepatitis BLung-Yi Mak, Wai-Kay Seto, James Fung, et al.
Expert Opinion on Emerging Drugs|March 5, 2016
Emerging drugs for the treatment of hepatitis BJames Fung, Ching-Lung Lai, Wai-Kay Seto, et al.
Hepatology International|June 21, 2011
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfectionWai-Kay Seto, Man-Fung Yuen, James Fung, et al.
Journal of Clinical Gastroenterology|August 24, 2012
Future prevention and treatment of chronic hepatitis B infectionWai-Kay Seto, James Fung, Man-Fung Yuen, et al.
Gut and Liver|March 29, 2019
New Biomarkers of Chronic Hepatitis BLung-Yi Mak, Wai-Kay Seto, James Fung, et al.
Journal of Gastroenterology and Hepatology|April 2, 2019
Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: A population-based studyKa Shing Cheung, Lijia Chen, Wai Kay Seto, et al.
Clinical and Molecular Hepatology|November 21, 2024
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis BSaisai Zhang, Lung-Yi Mak, Man-Fung Yuen, et al.
Clinical and Molecular Hepatology|November 30, 2022
Screening strategy for non-alcoholic fatty liver diseaseSaisai Zhang, Lung-Yi Mak, Man-Fung Yuen, et al.
Pageof 33